
Leadership Team
RedCarbonPharm is led by a team with deep experience across pharmaceutical strategy, commercialisation, intellectual property, and regulated product development, bringing together the expertise required to navigate complex regulatory, technical, and commercial environments.
Susan Glenny
-
Over 25 years’ experience in pharmaceutical leadership roles
-
Senior strategic marketing and commercial roles at global pharmaceutical companies
-
Founder and director of multiple healthcare-related ventures, with a focus on sustainable innovation and societal impact
John Young
-
Extensive experience in pharmaceutical operations and commercial execution
-
Background in supporting product development, scale-up, and cross-functional delivery in regulated environments
-
Focused on translating strategic intent into operationally viable programmes
Andrew Dean
-
Nearly 25 years’ experience across sales, marketing, partnering, and strategy in life sciences
-
Significant expertise in acquisitions, divestments, and strategic partnerships
-
Deep understanding of commercial value creation across pharmaceutical portfolios
Rikard Kange
-
Almost 20 years’ experience as a patent attorney in life sciences, pharmaceuticals, and materials science
-
Specialist expertise in intellectual property strategy for regulated healthcare technologies
-
Trusted advisor on complex patent matters spanning chemistry, materials, and process innovation
Susanne West PhD
-
Extensive experience in pharmaceutical operations and commercial execution
-
Background in supporting product development, scale-up, and cross-functional delivery in regulated environments
-
Focused on translating strategic intent into operationally viable programmes
Cressida Robson
-
25 years proven experience in global healthcare companies (Gilead, Eisai) and agencies.
-
Strong background in strategic communications and policy across diverse international markets and stakeholders